Dyax - Advancing Novel Biotherapeutics

Dedicated to finding new solutions for patients in need.

Stock quote

ExchangeNASDAQ (US Dollar)
Price$2.32
Change (%) Stock is Down 0.03 (1.28%)

Investor Relations Contacts

Ivana Magovcevic-Liebisch
Executive Vice President Corporate Development and General Counsel
Dyax Corp.
Phone: 617-225-2500


Nicole Jones
Director, Investor Relations and Corporate Communications
Dyax Corp.
Phone: 617-225-2500


JENNIFER VIERA
Manager, Investor Relations and Corporate Communications
Dyax Corp.
Phone: 617-225-2500